References
- Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science, 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Andersen, D. O., Weber, N. D., Wood, S. G., Hughes, B. G., Murray, B. K., & North, J. A. (1991). In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Research, 16(2), 185–196. https://doi.org/https://doi.org/10.1016/0166-3542(91)90024-L
- Arun, K. G., Sharanya, C. S., Abhithaj, J., Francis, D., & Sadasivan, C. (2020). Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1779819
- Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020). Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Computational and Structural Biotechnology Journal, 18, 784–790. https://doi.org/https://doi.org/10.1016/j.csbj.2020.03.025
- Berendsen, H. J. C., Postma, J. P. M., Gunsteren, W. F. v., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
- Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572
- Biovia, D. S. (2017). Discovery studio modeling environment. Release.
- Borkotoky, S., & Banerjee, M. (2020). A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/https://doi.org/10.1080/07391102.2020.1774419
- Chang, S. J., Chang, Y. C., Lu, K. Z., Tsou, Y. Y., & Lin, C. W. (2012). Antiviral activity of Isatis indigotica extract and its derived indirubin against Japanese encephalitis virus. Evidence-Based Complementary and Alternative Medicine, 2012, 925830. https://doi.org/https://doi.org/10.1155/2012/925830
- Chen, J. (2016). Drug resistance mechanisms of three mutations V32I, I47V and V82I in HIV-1 protease toward inhibitors probed by molecular dynamics simulations and binding free energy predictions. RSC Advances, 6(63), 58573–58585. https://doi.org/https://doi.org/10.1039/C6RA09201B
- Chen, J., Wang, X., Zhu, T., Zhang, Q., & Zhang, J. Z. (2015). A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods. Journal of Chemical Information and Modeling, 55(9), 1903–1913. https://doi.org/https://doi.org/10.1021/acs.jcim.5b00173
- Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223), 507–513. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30211-7
- Chou, K. C., Wei, D. Q., & Zhong, W. Z. (2003). Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochemical and Biophysical Research Communications, 308(1), 148–151. https://doi.org/https://doi.org/10.1016/S0006-291X(03)01342-1
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/https://doi.org/10.1038/srep42717
- Das, B. K., Pv, P., & Chakraborty, D. (2019). Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors. Computational Biology and Chemistry, 78, 37–52. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2018.11.005
- Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- Elmezayen, A. D., Al-Obaidi, A., Sahin, A. T., & Yelekci, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791
- Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1760136
- Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/https://doi.org/10.1063/1.470117
- Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., & Lai, L. (2004). Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. The Journal of Biological Chemistry, 279(3), 1637–1642. https://doi.org/https://doi.org/10.1074/jbc.M310875200
- Frisch, M., Clemente, F., Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., & Zhe, G. (2009). Gaussian 09, Revision A. 01.
- Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020a). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1779818
- Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020b). Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1802347
- Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL(pro)): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1764868
- Heredia, A., Davis, C., Bamba, D., Le, N., Gwarzo, M. Y., Sadowska, M., Gallo, R. C., & Redfield, R. R. (2005). Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS, 19(18), 2087–2095. https://doi.org/https://doi.org/10.1097/01.aids.0000194805.74293.11
- Hertel, L., Chou, S., & Mocarski, E. S. (2007). Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathogens, 3(1), e6. https://doi.org/https://doi.org/10.1371/journal.ppat.0030006
- Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
- Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. https://doi.org/https://doi.org/10.1021/ci100275a
- Hsu, M. F., Kuo, C. J., Chang, K. T., Chang, H. C., Chou, C. C., Ko, T. P., Shr, H. L., Chang, G. G., Wang, A. H., & Liang, P. H. (2005). Mechanism of the maturation process of SARS-CoV 3CL protease. The Journal of Biological Chemistry, 280(35), 31257–31266. https://doi.org/https://doi.org/10.1074/jbc.M502577200
- Hsuan, S. L., Chang, S. C., Wang, S. Y., Liao, T. L., Jong, T. T., Chien, M. S., Lee, W. C., Chen, S. S., & Liao, J. W. (2009). The cytotoxicity to leukemia cells and antiviral effects of Isatis indigotica extracts on pseudorabies virus. Journal of Ethnopharmacology, 123(1), 61–67. https://doi.org/https://doi.org/10.1016/j.jep.2009.02.028
- Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1760137
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
- Kim, H. K., Jeon, W. K., & Ko, B. S. (2001). Flavanone glycosides from Citrus junos and their anti-influenza virus activity. Planta Medica, 67(6), 548–549. https://doi.org/https://doi.org/10.1055/s-2001-16484
- Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K. O., & Pedersen, N. C. (2016). Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor. PLoS Pathogens, 12(3), e1005531. https://doi.org/https://doi.org/10.1371/journal.ppat.1005531
- Ko, H. C., Wei, B. L., & Chiou, W. F. (2006). The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. Journal of Ethnopharmacology, 107(2), 205–210. https://doi.org/https://doi.org/10.1016/j.jep.2006.03.004
- Lin, C. W., Tsai, F. J., Tsai, C. H., Lai, C. C., Wan, L., Ho, T. Y., Hsieh, C. C., & Chao, P. D. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research, 68(1), 36–42. https://doi.org/https://doi.org/10.1016/j.antiviral.2005.07.002
- Macchiagodena, M., Pagliai, M., & Procacci, P. (2020). Identification of potential binders of the main protease 3CL(pro) of the COVID-19 via structure-based ligand design and molecular modeling. Chemical Physics Letters, 750, 137489. https://doi.org/https://doi.org/10.1016/j.cplett.2020.137489
- Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020). Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An in silico based approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1768902
- Mak, N. K., Leung, C. Y., Wei, X. Y., Shen, X. L., Wong, R. N., Leung, K. N., & Fung, M. C. (2004). Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochemical Pharmacology, 67(1), 167–174. https://doi.org/https://doi.org/10.1016/j.bcp.2003.08.020
- Miyamoto, S., & Kollman, P. A. (1992). Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. Journal of Computational Chemistry, 13(8), 952–962. https://doi.org/https://doi.org/10.1002/jcc.540130805
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Morris, G. M., Huey, R., & Olson, A. J. (2008). Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics, Chapter 8, Unit 8 14. https://doi.org/https://doi.org/10.1002/0471250953.bi0814s24
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
- Odhar, H. A., Ahjel, S. W., Albeer, A., Hashim, A. F., Rayshan, A. M., & Humadi, S. S. (2020). Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus. Bioinformation, 16(3), 236–244. https://doi.org/https://doi.org/10.6026/97320630016236
- Oostenbrink, C., Villa, A., Mark, A. E., & van Gunsteren, W. F. (2004). A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. Journal of Computational Chemistry, 25(13), 1656–1676. https://doi.org/https://doi.org/10.1002/jcc.20090
- Paredes, A., Alzuru, M., Mendez, J., & Rodriguez-Ortega, M. (2003). Anti-Sindbis activity of flavanones hesperetin and naringenin. Biological & Pharmaceutical Bulletin, 26(1), 108–109. https://doi.org/https://doi.org/10.1248/bpb.26.108
- Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/https://doi.org/10.1063/1.328693
- Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/https://doi.org/10.1021/acs.jmedchem.5b00104
- Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., Jiang, Y. Z., Xiong, Y., Li, Y. J., Li, X. W., Li, H., Fan, G. H., Gu, X. Y., Xiao, Y., Gao, H., Xu, J. Y., Yang, F., Wang, X. M., Wu, C., … Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study. Chinese Medical Journal, 133(9), 1015–1024. https://doi.org/https://doi.org/10.1097/CM9.0000000000000722
- Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Penaranda, S., Bankamp, B., Maher, K., Chen, M. H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q., Wang, D., Erdman, D. D., Peret, T. C., … Bellini, W. J. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300(5624), 1394–1399. https://doi.org/https://doi.org/10.1126/science.1085952
- Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020). High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging Infectious Diseases, 26(7), 1470–1477. https://doi.org/https://doi.org/10.3201/eid2607.200282
- Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/https://doi.org/10.1107/S0907444904011679
- Semple, S. J., Pyke, S. M., Reynolds, G. D., & Flower, R. L. (2001). In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Research, 49(3), 169–178. https://doi.org/https://doi.org/10.1016/S0166-3542(01)00125-5
- Tahir Ul Qamar, M., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313–319. https://doi.org/https://doi.org/10.1016/j.jpha.2020.03.009
- Tang, B., Bragazzi, N. L., Li, Q., Tang, S., Xiao, Y., & Wu, J. (2020). An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious Disease Modelling, 5, 248–255. https://doi.org/https://doi.org/10.1016/j.idm.2020.02.001
- Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., & Kiyotani, K. (2020). SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. Journal of Human Genetics, 65(12), 1075–1082. https://doi.org/https://doi.org/10.1038/s10038-020-0808-9
- Umesh, K. D., Selvaraj, C., Singh, S. K., & Dubey, V. K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1763202
- Zheng, J. (2020). SARS-CoV-2: An emerging coronavirus that causes a global threat. International Journal of Biological Sciences, 16(10), 1678–1685. https://doi.org/https://doi.org/10.7150/ijbs.45053
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., & China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017
- Zou, P., & Koh, H. L. (2007). Determination of indican, isatin, indirubin and indigotin in Isatis indigotica by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 21(7), 1239–1246. https://doi.org/https://doi.org/10.1002/rcm.2954